Thyroid Carcinoma, Anaplastic
"Thyroid Carcinoma, Anaplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It is associated with CELL DEDIFFERENTIATION of THYROID CARCINOMA (e.g., FOLLICULAR THYROID CARCINOMA; PAPILLARY THYROID CANCER). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with DYSPHAGIA; NECK PAIN; bone pain; DYSPNEA; and NEUROLOGIC DEFICITS.
| Descriptor ID |
D065646
|
| MeSH Number(s) |
C04.557.470.200.725
|
| Concept/Terms |
Thyroid Carcinoma, Anaplastic- Thyroid Carcinoma, Anaplastic
- Anaplastic Thyroid Carcinoma
- Anaplastic Thyroid Carcinomas
- Carcinoma, Anaplastic Thyroid
- Carcinomas, Anaplastic Thyroid
- Thyroid Carcinomas, Anaplastic
- Thyroid Cancer, Anaplastic
- Anaplastic Thyroid Cancer
- Anaplastic Thyroid Cancers
- Cancer, Anaplastic Thyroid
- Cancers, Anaplastic Thyroid
- Thyroid Cancers, Anaplastic
|
Below are MeSH descriptors whose meaning is more general than "Thyroid Carcinoma, Anaplastic".
Below are MeSH descriptors whose meaning is more specific than "Thyroid Carcinoma, Anaplastic".
This graph shows the total number of publications written about "Thyroid Carcinoma, Anaplastic" by people in this website by year, and whether "Thyroid Carcinoma, Anaplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 5 | 0 | 5 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Thyroid Carcinoma, Anaplastic" by people in Profiles.
-
Dramatic clinical response to dabrafenib plus trametinib in anaplastic thyroid carcinoma and the challenges faced during the COVID-19 pandemic. Arch Endocrinol Metab. 2021 Nov 01; 65(2):242-247.
-
Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma. Anticancer Res. 2019 Mar; 39(3):1119-1127.
-
Bromodomain-containing protein 4 is critical for the antiproliferative and pro-apoptotic effects of gambogic acid in anaplastic thyroid cancer. Int J Mol Med. 2018 Jul; 42(1):161-170.
-
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo. Oncol Rep. 2018 May; 39(5):2225-2234.
-
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo. Oncol Rep. 2018 May; 39(5):2306-2314.
-
Anaplastic Carcinoma Thyroid in a Young Child - an Extremely Rare Occurrence. Acta Medica (Hradec Kralove). 2018; 61(4):150-152.
-
CCL2 is Modulated by Cytokines and PPAR-? in Anaplastic Thyroid Cancer. Anticancer Agents Med Chem. 2018; 18(3):458-466.
-
Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer. Cancer Lett. 2017 12 28; 411:35-43.
-
Precision Medicine Approach to Anaplastic Thyroid Cancer: Advances in Targeted Drug Therapy Based on Specific Signaling Pathways. Acta Med Iran. 2017 Mar; 55(3):200-208.
-
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case report. Medicine (Baltimore). 2017 Feb; 96(6):e5621.